Heba M. Abo‐Salem

456 total citations
37 papers, 362 citations indexed

About

Heba M. Abo‐Salem is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Heba M. Abo‐Salem has authored 37 papers receiving a total of 362 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 12 papers in Molecular Biology and 7 papers in Pharmacology. Recurrent topics in Heba M. Abo‐Salem's work include Synthesis and biological activity (24 papers), Synthesis and Biological Evaluation (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Heba M. Abo‐Salem is often cited by papers focused on Synthesis and biological activity (24 papers), Synthesis and Biological Evaluation (9 papers) and Synthesis and Characterization of Heterocyclic Compounds (8 papers). Heba M. Abo‐Salem collaborates with scholars based in Egypt, Saudi Arabia and United States. Heba M. Abo‐Salem's co-authors include Eslam R. El‐Sawy, Mohamed S. Abdel‐Aziz, Abdullah G. Al‐Sehemi, Salwa M. El‐Hallouty, Kamel H. Shaker, Khaled Mahmoud, Eman AboBakr Ali, Mohammed A. Hussein, Ali Ali and Anhar Abdel‐Aziem and has published in prestigious journals such as Scientific Reports, Molecules and International Journal of Biological Macromolecules.

In The Last Decade

Heba M. Abo‐Salem

36 papers receiving 354 citations

Peers

Heba M. Abo‐Salem
Heba M. Abo‐Salem
Citations per year, relative to Heba M. Abo‐Salem Heba M. Abo‐Salem (= 1×) peers Avneet Kaur

Countries citing papers authored by Heba M. Abo‐Salem

Since Specialization
Citations

This map shows the geographic impact of Heba M. Abo‐Salem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heba M. Abo‐Salem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heba M. Abo‐Salem more than expected).

Fields of papers citing papers by Heba M. Abo‐Salem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heba M. Abo‐Salem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heba M. Abo‐Salem. The network helps show where Heba M. Abo‐Salem may publish in the future.

Co-authorship network of co-authors of Heba M. Abo‐Salem

This figure shows the co-authorship network connecting the top 25 collaborators of Heba M. Abo‐Salem. A scholar is included among the top collaborators of Heba M. Abo‐Salem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heba M. Abo‐Salem. Heba M. Abo‐Salem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Rashedy, Ahmed A., et al.. (2025). Design, synthesis, and molecular modeling of new 1,2,4-triazole-containing indole compounds as aromatase antagonists for the treatment of breast cancer. Bioorganic Chemistry. 163. 108677–108677. 2 indexed citations
2.
Abo‐Salem, Heba M., et al.. (2025). A novel 1,2,4-triazole derivative inhibits epithelial-mesenchymal transition in metastatic colorectal cancer via β-catenin suppression. European Journal of Medicinal Chemistry. 302(Pt 1). 118279–118279.
3.
Salam, Hayam A. Abd El, Heba M. Abo‐Salem, Omnia Kutkat, et al.. (2024). Synthesis of 5-heptadecyl-4H-1,2,4-triazole incorporated indole moiety: Antiviral (SARS-CoV-2), antimicrobial, and molecular docking studies. Journal of Molecular Structure. 1303. 137517–137517. 13 indexed citations
5.
Abo‐Salem, Heba M., et al.. (2024). Anti colorectal cancer activity and in silico studies of novel pyridine nortopsentin analog as cyclin dependent kinase 6 inhibitor. Scientific Reports. 14(1). 26327–26327. 2 indexed citations
6.
Abo‐Salem, Heba M., et al.. (2024). Chitosan nanoparticles of new chromone-based sulfonamide derivatives as effective anti-microbial matrix for wound healing acceleration. International Journal of Biological Macromolecules. 272(Pt 1). 132631–132631. 9 indexed citations
7.
Abo‐Salem, Heba M., et al.. (2024). Synthesis, bioactivity assessment, molecular docking and ADMET studies of new chromone congeners exhibiting potent anticancer activity. Scientific Reports. 14(1). 9636–9636. 11 indexed citations
8.
Soliman, Kamal A., et al.. (2023). Synthesis and investigation of the structure, thermal, optical, and electrical properties of poly (indol-thiazolo-thiadiazole) derivatives at room temperature. Materials Science and Engineering B. 299. 117018–117018. 1 indexed citations
9.
10.
Ali, Eman AboBakr, et al.. (2023). Chitosan Schiff base electrospun fabrication and molecular docking assessment for nonleaching antibacterial nanocomposite production. Cellulose. 30(6). 3505–3522. 18 indexed citations
11.
Abo‐Salem, Heba M., et al.. (2022). A novel thiourea based interfacial modifier for silica‐filled natural rubber composites. Journal of Applied Polymer Science. 140(9). 3 indexed citations
12.
Abo‐Salem, Heba M., et al.. (2020). Synthesis, Molecular Docking and Biological Evaluation of Novel Flavone Derivatives as Potential Anticancer Agents Targeting Akt. Medicinal Chemistry. 17(2). 158–170. 12 indexed citations
13.
Abo‐Salem, Heba M., Amr Nassrallah, Ahmed A. F. Soliman, et al.. (2020). Synthesis and Bioactivity Assessment of Novel Spiro Pyrazole-Oxindole Congeners Exhibiting Potent and Selective in vitro Anticancer Effects. Molecules. 25(5). 1124–1124. 24 indexed citations
14.
Abo‐Salem, Heba M., et al.. (2020). Synthesis, Anti-Proliferative Activity and SAR studies of Novel 5-(3-Indolyl)-5H-Thiazolo[4,3-b][1,3,4]Thiadiazoles tethered with Steroid Moieties. Egyptian Journal of Chemistry. 0(0). 0–0. 2 indexed citations
15.
Shalby, Aziza B., et al.. (2017). Synthesis and molecular docking of novel non-Cytotoxic, anti-Angiogenic sulfonyl coumarin derivatives against hepatocellular carcinoma cells In Vitro. Journal of Applied Pharmaceutical Science. 7(2). 49–66. 5 indexed citations
16.
Abo‐Salem, Heba M., et al.. (2013). Synthesis and DPPH radical-scavenging activity of some new 5-(N-substituted-1H-indol-3-yl)-5H-thiazolo[4,3-b]-1,3,4-thiadiazole derivatives. Egyptian Pharmaceutical Journal. 12(1). 11. 3 indexed citations
17.
18.
El‐Sawy, Eslam R., et al.. (2012). Some New 2-Amino-4-(N-substituted-1H- indol - 3-yl) thiophene-3-carbonitriles and their Antimicrobial Properties. Egyptian Journal of Chemistry. 55(3). 239–258. 2 indexed citations
19.
El‐Sawy, Eslam R., et al.. (2012). Synthesis, antimicrobial and anti-cancer activities of some new N-ethyl, N-benzyl and N-benzoyl-3-indolyl heterocycles. Acta Pharmaceutica. 62(2). 157–179. 26 indexed citations
20.
El‐Sawy, Eslam R., et al.. (2011). Synthesis of A New Series of N-Substituted-3-Indolyl-Heterocycles for Antimicrobial Evaluation. Egyptian Journal of Chemistry. 54(1). 141–154. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026